3D Printing of Pharmaceutical Drug Delivery Systems

Journal Title: Archives of Organic and Inorganic Chemical Sciences - Year 2018, Vol 1, Issue 2

Abstract

Drug delivery refers to approaches, systems, technologies and formulations for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. The concept of drug delivery has greatly evolved over the years from immediate-release oral dosage forms to targeted-release drug delivery systems. Indeed, the necessity of controlling the drug release profile to modulate the absorption, the distribution, the metabolization and the elimination of the drug rapidly appeared as a key factor for improving product efficacy and safety as well as to increase the compliance of the patients [1]. In the drug delivery area, versatile therapeutic systems intended to yield customized combinations of drugs, drug doses and release kinetics have drawn increasing attention, especially because of the advantages that personalized pharmaceutical treatments would offer [2]. Three dimensional printing (3DP) technology is a novel technique for rapid prototyping, which constructs solid objects by deposition of several layers in sequence. The introduction and application of 3D printing have promoted enormous innovations in many diverse fields, including aerospace industry, architecture, tissue engineer, biomedical research and pharmacy. It seems that 3D printing technology will lead a new epoch of the next industrial revolution based on its versatility and diversity. Along with development and progress in science and technology, the 3D printing technology gets mature enough so that anyone can apply it with open-source software at a relative lower material cost [3]. The recent introduction of the first FDA approved 3D-printed drug has fuelled interest in 3D printing technology, which is set to revolutionize healthcare. Since its initial use, this rapid prototyping (RP) technology has evolved to such an extent that it is currently being used in a wide range of applications including in tissue engineering, dentistry, construction, automotive and aerospace. However, in the pharmaceutical industry this technology is still in its infancy and it's potential yet to be fully explored [4].

Authors and Affiliations

Diogo José Horst

Keywords

Related Articles

Improved Enantioselective Enzymatic Synthesis of (S) - Pregabalin

Pregabalin is available in the market under the brand name of Lyrica among others. It is a drug of choice for the treatment of epilepsy, fibromyalgia, sweeping anxiety disorder and neuropathic pai...

Level of Some Adipokines in Obese Type 2 Diabetic Egyptian Patients with Coronary Artery Stenosis

Cardiovascular diseases (CVD) are the leading global cause of death accounting for 17.5 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. Cardiovascular diseases res...

Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi Via Quantum Chemistry using Ab Initio, Hartree-Fock Method in the Base Set CC-Pvtz and 6-311G**(3df, 3pd)

The work characterizes the electric dipole moment and the infrared spectrum of the molecule C13H20BeLi2SeSi. Calculations obtained in the ab initio RHF (Restrict Hartree-Fock) method, on the set of bases used indicate th...

Chemical Characterization on the Aromatic Composition of Cedrus Atlantica from Morocco in Two Geographical Areas will Break

Essential oils have various properties in different fields of application. This work entitled on the chemical characterization of Cedrus Atlantica of Morocco in two geographical zones will break: Cedrus Atlantica of Ajdi...

Biological Studies, Synthesis, Structural, Spectral Characterization and Co-Ordinate Mn (II), Fe (II), Zn (II) (II) Complexes Containing 2-Hydroxy-1- Naphthaldehydeand n,n’-Dimethyl-1,3-Propanediamine

Metal chelates are capable to tolerate their antitumor effects by binding to DNA. DNA binding alters the replication of DNA by inhibiting the growth of the tumor cells, which is the basis of designing new and more effect...

Download PDF file
  • EP ID EP576750
  • DOI 10.32474/AOICS.2018.01.000109
  • Views 74
  • Downloads 0

How To Cite

Diogo José Horst (2018). 3D Printing of Pharmaceutical Drug Delivery Systems. Archives of Organic and Inorganic Chemical Sciences, 1(2), 65-69. https://europub.co.uk/articles/-A-576750